PharmaCyte Biotech Inc (PMCB)

[1234jklm]

When. Not if.


Being a long on an otc bio is not much fun....

Until the day it achieves its disruptive medical goals and starts saving people’s lives and the mainstream media starts telling everyone.

Until then you look back and think if I’d sold at 10 I could have bought back at six and made a small profit. You do that quite a few times as the mms move it up and down to take their slither.

But it’s a bit like the turkey at thanksgiving. Just because you get fed and fattened up every day it doesn’t mean it will always be like that. One day everything changes. And when you sold at 10 but it keeps going up you realize it’s going to be very tough to get back in now everyone knows it’s value.

One day the ind will be submitted and accepted and early trial results will drop or breakthrough therapy and those who have held will get a mega payout and those who couldn’t get back in will chase and chase and miss the bulk of the payout when it partners or sells.

In the meantime it’s not much fun.

But it’s the only way to be sure you’ll be there for the jackpot.

This is a news stock. The right news will be huge.

And I don’t think it will be much longer although I really don’t know. But recent news has been accumulating key good and our biggest hurdles are behind us now. There is no doubt the company is vastly improved from last year.

It’s now a question of when and not if.